Literature DB >> 16567619

NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression.

Adam Rosendorff1, Shuhei Sakakibara, Sixin Lu, Elliott Kieff, Yan Xuan, Alessandra DiBacco, Yujiang Shi, Yang Shi, Grace Gill.   

Abstract

Small ubiquitin-like modifier (SUMO) modification of transcription factors is generally associated with repression. Reverse genetic analysis of SUMO-1, and -2 conserved residues emphasized the importance of dual charge reversals in abrogating the critical role of SUMO-2 K33, K35, and K42 in repression. GST-SUMO-2-affinity chromatography followed by liquid chromatography (LC)-MS analysis identified proteins that appeared to bind preferentially to WT SUMO-2 versus SUMO-2 K33E and K35E. LSD1, NXP-2, KIAA0809 (ARIP4), SAE2, RanGAP1, PELP1, and SETDB1 bound to SUMO-2 and not to SUMO-2 K33E, K42E, or K35E and K42E. Although LSD1 is a histone lysine demethylase, and histone H3K4 was demethylated at a SUMO-2-repressed promoter, neither overexpression of a dominant-negative LSD1 nor LSD1 depletion with RNA interference affected SUMO-2-mediated repression, indicating that LSD1 is not essential for repression, in this context. When tethered to a promoter by fusion to Gal4, NXP-2 repressed transcription, consistent with a role for NXP-2 in SUMO-mediated repression. SUMO-2-associated proteins identified in this study may contribute to SUMO-dependent regulation of transcription or other processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567619      PMCID: PMC1459351          DOI: 10.1073/pnas.0601066103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Regulation of transcriptional activation domain function by ubiquitin.

Authors:  S E Salghetti; A A Caudy; J G Chenoweth; W P Tansey
Journal:  Science       Date:  2001-07-19       Impact factor: 47.728

2.  The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains.

Authors:  Yukio Kimura; Fumie Sakai; Osami Nakano; Osamu Kisaki; Hiroaki Sugimoto; Takashi Sawamura; Hiroyuki Sadano; Takashi Osumi
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

3.  SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.

Authors:  David C Schultz; Kasirajan Ayyanathan; Dmitri Negorev; Gerd G Maul; Frank J Rauscher
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

4.  New structural clues to substrate specificity in the "ubiquitin system".

Authors:  Mark Hochstrasser
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

5.  Crystal structure of thymine DNA glycosylase conjugated to SUMO-1.

Authors:  Daichi Baba; Nobuo Maita; Jun-Goo Jee; Yasuhiro Uchimura; Hisato Saitoh; Kaoru Sugasawa; Fumio Hanaoka; Hidehito Tochio; Hidekazu Hiroaki; Masahiro Shirakawa
Journal:  Nature       Date:  2005-06-16       Impact factor: 49.962

6.  PIASx acts as an Elk-1 coactivator by facilitating derepression.

Authors:  Shen-Hsi Yang; Andrew D Sharrocks
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

7.  Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.

Authors:  Jeffrey Lin; Eric Johannsen; Erle Robertson; Elliott Kieff
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

8.  Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.

Authors:  David Reverter; Christopher D Lima
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

9.  The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2.

Authors:  Motoki Saito; Fuyuki Ishikawa
Journal:  J Biol Chem       Date:  2002-07-17       Impact factor: 5.157

10.  Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription.

Authors:  Nathalie Rouleau; Andrii Domans'kyi; Mati Reeben; Anu-Maarit Moilanen; Kristina Havas; Zhigang Kang; Tom Owen-Hughes; Jorma J Palvimo; Olli A Jänne
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

View more
  57 in total

1.  Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Authors:  Theodora E Danciu; Sergey Chupreta; Osvaldo Cruz; Jennifer E Fox; Malcolm Whitman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

2.  The MORC family: new epigenetic regulators of transcription and DNA damage response.

Authors:  Da-Qiang Li; Sujit S Nair; Rakesh Kumar
Journal:  Epigenetics       Date:  2013-05-17       Impact factor: 4.528

3.  Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

Authors:  Serena Ghisletti; Wendy Huang; Sumito Ogawa; Gabriel Pascual; Mu-En Lin; Timothy M Willson; Michael G Rosenfeld; Christopher K Glass
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

4.  Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.

Authors:  M Kuppuswamy; S Vijayalingam; Ling-Jun Zhao; Yun Zhou; T Subramanian; Jan Ryerse; G Chinnadurai
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

5.  SUMO-modified Sp3 represses transcription by provoking local heterochromatic gene silencing.

Authors:  Bastian Stielow; Alexandra Sapetschnig; Christina Wink; Imme Krüger; Guntram Suske
Journal:  EMBO Rep       Date:  2008-07-11       Impact factor: 8.807

6.  Regulation of aromatase induction by nuclear receptor coregulator PELP1.

Authors:  Ratna K Vadlamudi; Rajib Rajhans; Dimple Chakravarty; Binoj C Nair; Sujit S Nair; Dean B Evans; Shiuan Chen; Rajeshwar Rao Tekmal
Journal:  J Steroid Biochem Mol Biol       Date:  2009-09-30       Impact factor: 4.292

Review 7.  Myositis-specific autoantibodies: detection and clinical associations.

Authors:  Sander H J van Dooren; Walther J van Venrooij; Ger J M Pruijn
Journal:  Auto Immun Highlights       Date:  2011-03-23

8.  Five friends of methylated chromatin target of protein-arginine-methyltransferase[prmt]-1 (chtop), a complex linking arginine methylation to desumoylation.

Authors:  Pavlos Fanis; Nynke Gillemans; Ali Aghajanirefah; Farzin Pourfarzad; Jeroen Demmers; Fatemehsadat Esteghamat; Ratna K Vadlamudi; Frank Grosveld; Sjaak Philipsen; Thamar B van Dijk
Journal:  Mol Cell Proteomics       Date:  2012-08-07       Impact factor: 5.911

Review 9.  PELP1: A novel therapeutic target for hormonal cancers.

Authors:  Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

10.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.